# Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease

Study · id `cardio:ct-nct04142125` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04142125](<https://clinicaltrials.gov/study/NCT04142125>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04142125

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 101 participants.

## Technical summary

Registry record NCT04142125. Randomized; single masking; primary purpose treatment. Start 2020-02-03 (actual); primary completion 2023-09-18 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 101 participants (enrolled count; ClinicalTrials.gov record NCT04142125, source copy `cardio:ctgov-nct04142125-2023-09-26`, retrieved 2026-10-26)
- Started: 2020-02-03 (actual) (ClinicalTrials.gov record NCT04142125, source copy `cardio:ctgov-nct04142125-2023-09-26`, retrieved 2026-10-26)
- Primary completion: 2023-09-18 (actual) (ClinicalTrials.gov record NCT04142125, source copy `cardio:ctgov-nct04142125-2023-09-26`, retrieved 2026-10-26)
- Completion: 2023-09-18 (actual) (ClinicalTrials.gov record NCT04142125, source copy `cardio:ctgov-nct04142125-2023-09-26`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT04142125, source copy `cardio:ctgov-nct04142125-2023-09-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04142125-2023-09-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease
- Condition: Ischemic Stroke
- Condition: Intracranial Atherosclerotic Disease
- Intervention (Drug): Rivaroxaban 2.5 Mg Oral Tablet bid
- Intervention (Drug): Acetylsalicyclic acid 81 mg tablet qd
- Lead sponsor: Population Health Research Institute
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Population Health Research Institute (`cardio:org-population-health-research-institute`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Combination Antithrombotic Therapy for Reduction of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease (`cardio:pubmed-39781748`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c032eb137b33793be9306b06e71ae7a785f69da06e5ac0e60ff9da08d1327509
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
